SpinalMotion closes 4th tranche of $15M round | Wall Street Beat

MassDevice.com Wall Street Beat

SpinalMotion closed the final tranche of a $15 million funding round that began in June 2011, according to a regulatory filing.

The Mountain View, Calif.-based medical device company raised a total of $15.1 million in the offering of debt, options and warrants from 15 unnamed investors, according to the filing.

The first tranche of $7.7 million closed June 2, 2011, according to the SEC filing. A 2nd, $3.0 million round closed April 17, 2012; a 3rd round worth $2.8 million closed Sept. 6, 2012; and the final, $1.5 million round closing Jan. 11 of this year.

Sign up to get our free newsletters delivered straight to your inbox

SpinalMotion won CE Mark approval in the European Union for a pair of its Kineflex cervical disc implants in March 2012.

 Manning & Napier takes 8% stake in Volcano
Manning & Napier Advisors bought some 4.2 million shares of Volcano (NSDQ:VOLC) stock worth about a 7.7% stake in the medical device company.
Read more

 GE Healthcare looks to bring imaging agent ops in-house
GE (NYSE:GE) said it filed a supplemental new drug application with the FDA to bring the manufacture of its Optison imaging agent in-house.
Read more

 Clal Biotech said to shop wound care biz
Clal Biotechnology Industries hired Jefferies Group to shop its wound care business after Teva Pharmaceutical (NYSE:TEVA) killed a deal to market MediWound’s PolyHeal and NexoBrid products.
Read more

 Haemonetics hits 52-week high

Haemonetics (NYSE:HAE)
shares hit a 52-week high today, reaching a peak of $43.81 before closing at $43.56 apiece, down 0.2% on the day.
Read more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): Leerink Swann reiterates "market perform" rating, $30 price target; TheStreet Ratings downgrades to "hold" rating.
  • Amgen (NSDQ:AMGN): Credit Suisse downgrades from outperform to neutral rating, $90 price target.
  • Baxter (NYSE:BAX): RBC Capital restates "outperform" rating, $70 price target.
  • Becton Dickinson & Co. (NYSE:BDX): Mizuho Securities downgrades from Outperform to Neutral, price target of $87.
  • Intuitive Surgical (NSDQ:ISRG): Lazard raises price target to $625, Buy rating; Leerink Swann maintains "market perform" rating, $580 price target.
  • Johnson & Johnson (NYSE:JNJ): Leerink Swann maintains "outperform" rating, raises price target to $80 from $76.
  • Optos plc (LON:OPTS): Jefferies Group reiterates buy rating, $4.43 (£2.80) price target.
  • St. Jude Medical (NYSE:STJ): Leerink Swann reiterates "outperform" rating, ~$50 price target.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply